Position in VSTM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$190,824
-$3,344,329 QoQ
Shares Held
49,954
-92.5% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 158 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in VSTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. VSTM ranks #297 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in VSTM
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $190,824 | 49,954 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,535,153 | 667,010 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,681,606 | 476,892 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,746,145 | 424,252 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,436,137 | 587,021 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $618,340 | 102,544 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $421,137 | 81,458 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $300,629 | 100,545 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $30,053 | 10,085 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $142,567 | 12,082 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $184,061 | 22,612 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $367,435 | 45,195 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $640,680 | 86,113 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $78,428 | 186,734 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $220,379 | 550,948 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $340,998 | 401,175 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $443,114 | 381,995 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,519,080 | 1,077,362 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,499,444 | 1,219,241 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,855,526 | 1,901,145 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $9,253,836 | 2,273,670 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $5,340,871 | 2,162,296 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,142,353 | 536,316 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $61,947 | 36,016 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||